Á lódáil...
Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment
BACKGROUND: Evidence on whether the therapeutic effect and good safety profile of onabotulinumtoxinA (Botox®) in chronic migraine (CM) patients is maintained over long term treatment is still limited. We herein aimed at assessing whether there is a sustained benefit and good safety with repeated ona...
Na minha lista:
| Foilsithe in: | J Headache Pain |
|---|---|
| Main Authors: | , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Springer Milan
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6755578/ https://ncbi.nlm.nih.gov/pubmed/30225735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0918-3 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|